Jennifer Hand
Nurse Practitioner · Monmouth
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 4
- Since medical school
- 7 years
- Graduated 2019
Offices
4 locations · Henderson County Rural Health Center, Inc · Southeast Iowa Regional Medical Center Inc
Looking this up.
Hospitals listed: Southeast Iowa Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Jennifer Hand’s office to ask if they take your plan before you enroll.
State licence records
1 licence
- Illinois 209020910Advanced Practice Registered Nurse · since 2020 · expires 2028-05-31Specialty on the licence: MastersActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Southeast Iowa Regional Medical CenterWest Burlington, IAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Great River Health SystemsPatients rate it 2 of 5 · 56% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 1.53 (1.14 to 1.91), Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 2.31 (1.47 to 3.15) · 2,741 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.316, Oct 2024 – Sep 2025
See every measure and the patient survey for Southeast Iowa Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 1 better, 9 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.53 (1.14 to 1.91) | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 2.31 (1.47 to 3.15) · 2,741 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.316 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.13 to 2.14) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 190.89 (133.87 to 247.92) · 47 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.8 · 206 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14.5 · 385 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.9 · 448 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8 · 151 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 1,564 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.4) · 3,878 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.07 to 0.48) · 3,802 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.18 (2.93 to 7.43) · 765 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.33 to 3.67) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.7 to 3.92) · 718 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.79 (0 to 15.45) · 208 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.09 (2.1 to 10.08) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.15) · 156 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5 · 28 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.216 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.264 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.957 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.4 · 175 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.8 · 409 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 7.5 · 173 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 35.4 · 441 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 476 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.2 · 489 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.3 to 8.5) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (7.7 to 13) · 244 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 212 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (10.2 to 16.8) · 2,019 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (1 to 1.5) · 829 cases | No different | Jan 2024 – Dec 2024 |
What patients said (642 patients answered, 28% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 3 |
| Recommend hospital | 2 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 52% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 65% |
| Doctors "always" listened carefully | 70% |
| Doctors "always" treated them with courtesy and respect | 79% |
| Patients who gave a rating of "9" or "10" (high) | 59% |
| Staff "always" explained new medications | 62% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 56% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$301
Medicare paid this office $301 for 21 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
21 Original Medicare patients in 2024. Average age 67 · Health risk score 0.92. At or below the middle of the specialty; the typical nurse practitioner clinician is at 1.42.
Conditions among them: High blood pressure 71%.
The office billed $1,422, Medicare allowed $313 and paid $301; for 37 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 21 | 37 | 67 | 0.92 | $1,422 | $301 |
| 2023 | 23 | 39 | 67 | 1.73 | $2,137 | $1,076 |
| 2022 | 87 | 279 | 79 | 2.45 | $41,336 | $17,639 |
| 2021 | 120 | 396 | 78 | 1.98 | $55,546 | $25,804 |
| 2020 | 174 | 421 | 78 | 2.03 | $54,837 | $26,075 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2022: 3 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 49 | $7,898 | $57 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 60 | $6,502 | $86 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 26 | $2,362 | $45 |
2021: 4 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 60 | $10,382 | $60 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 76 | $9,140 | $90 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 27 | $3,380 | $60 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 21 | $2,419 | $90 |
2020: 5 services
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 94 | $10,592 | $62 |
| Subsequent nursing facility care with moderate level of medical decision making, per day at least 30 minutes | 33 | $6,281 | $62 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 40 | $4,456 | $91 |
| Subsequent nursing facility care with high level of medical decision making, per day at least 45 minutes | 27 | $2,728 | $91 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day at least 10 minutes | 16 | $484 | $30 |
Medicaid work
$441 in 2021
Medicaid paid $441 for 18 billed services this clinician did in 2021, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ NURSING FACILITY CARE MOD MDM 30 MINUTES | 18 | $441 |
| 2021 | 18 | 1 | 13 | $441 |
Drugs they prescribed that Part D paid
$169,522
Pharmacies billed $169,522 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
1,513 generic and 267 brand-name prescriptions · $169,522 in drug cost · 38 antibiotic prescriptions to 27 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mounjaro | 38 | $40,204 | $1,058 |
| Jardiance | 34 | $23,602 | $694 |
| Eliquis | 34 | $18,680 | $549 |
| Gabapentin | 42 | $1,503 | $36 |
| Atorvastatin | 100 | $889 | $9 |
See all 44 drugs
| Mounjaro | 38 | $40,204 | $1,058 |
| Jardiance | 34 | $23,602 | $694 |
| Eliquis | 34 | $18,680 | $549 |
| Gabapentin | 42 | $1,503 | $36 |
| Atorvastatin | 100 | $889 | $9 |
| Lansoprazole | 14 | $767 | $55 |
| Ultra-Fine Short Pen Needle | 13 | $712 | $55 |
| Levothyroxine | 80 | $692 | $9 |
| Albuterol Sulfate Hfa | 32 | $622 | $19 |
| Venlafaxine | 19 | $612 | $32 |
| Omeprazole | 42 | $570 | $14 |
| Oxybutynin Chloride Er | 19 | $560 | $29 |
| Buprenorphine-Naloxone | 12 | $525 | $44 |
| Metformin | 47 | $521 | $11 |
| Metoprolol | 46 | $482 | $10 |
| Cilostazol | 13 | $479 | $37 |
| Losartan | 65 | $395 | $6 |
| Lisinopril | 70 | $383 | $5 |
| Alendronate | 26 | $360 | $14 |
| Famotidine | 24 | $286 | $12 |
| Simvastatin | 38 | $285 | $7 |
| Amlodipine Besylate | 67 | $243 | $4 |
| Citalopram Hbr | 26 | $242 | $9 |
| Bupropion | 14 | $227 | $16 |
| Metoprolol | 17 | $226 | $13 |
| Sertraline | 23 | $216 | $9 |
| Warfarin | 15 | $206 | $14 |
| Fluticasone Propionate | 14 | $205 | $15 |
| Clopidogrel | 19 | $191 | $10 |
| Tamsulosin | 16 | $188 | $12 |
| Glipizide | 15 | $188 | $13 |
| Trazodone | 19 | $174 | $9 |
| Spironolactone | 23 | $172 | $7 |
| Pravastatin | 20 | $171 | $9 |
| Glipizide Er | 22 | $161 | $7 |
| Pantoprazole | 16 | $156 | $10 |
| Furosemide | 30 | $155 | $5 |
| Duloxetine | 12 | $132 | $11 |
| Amoxicillin-Clavulanate Potass | 18 | $112 | $6 |
| Nystatin | 17 | $102 | $6 |
| Hydrochlorothiazide | 38 | $95 | $2 |
| Losartan-Hydrochlorothiazide | 11 | $91 | $8 |
| Prednisone | 13 | $66 | $5 |
| Montelukast | 20 | $50 | $3 |
Year by year
| 2024 | 1,804 | 161 | None | 15% | $169,522 |
| 2023 | 1,817 | 135 | 2% (30) | None | $132,878 |
| 2022 | 2,012 | 208 | 8% (165) | 16% | $176,747 |
| 2021 | 1,769 | 199 | 5% (94) | 17% | $179,823 |
| 2020 | 424 | 142 | 12% (52) | None | $22,086 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 47 drugs
| Jardiance | 58 | $20,469 | $353 |
| Eliquis | 67 | $19,171 | $286 |
| Novolog Flexpen | 11 | $4,959 | $451 |
| Soliqua 100-33 | 11 | $3,891 | $354 |
| Duloxetine | 23 | $1,516 | $66 |
| Gabapentin | 48 | $1,412 | $29 |
| Levothyroxine | 90 | $1,404 | $16 |
| Atorvastatin | 63 | $972 | $15 |
| Venlafaxine | 23 | $858 | $37 |
| Albuterol Sulfate Hfa | 30 | $813 | $27 |
| Losartan | 60 | $761 | $13 |
| Oxybutynin Chloride Er | 17 | $744 | $44 |
| Tizanidine | 12 | $571 | $48 |
| Levetiracetam | 23 | $511 | $22 |
| Furosemide | 69 | $492 | $7 |
| Potassium Chloride | 26 | $445 | $17 |
| Lisinopril | 47 | $436 | $9 |
| Omeprazole | 37 | $434 | $12 |
| Metformin | 33 | $390 | $12 |
| Hydrochlorothiazide | 36 | $382 | $11 |
| Metoprolol | 23 | $374 | $16 |
| Ondansetron | 15 | $369 | $25 |
| Hydrocodone-Acetaminophen | 19 | $335 | $18 |
| Pantoprazole | 26 | $310 | $12 |
| Clopidogrel | 13 | $294 | $23 |
| Fluticasone Propionate | 19 | $287 | $15 |
| Amlodipine Besylate | 40 | $285 | $7 |
| Fluoxetine | 14 | $280 | $20 |
| Citalopram Hbr | 31 | $278 | $9 |
| Allopurinol | 19 | $263 | $14 |
| Simvastatin | 21 | $256 | $12 |
| Metoprolol | 30 | $243 | $8 |
| Trazodone | 36 | $241 | $7 |
| Spironolactone | 30 | $232 | $8 |
| Alendronate | 25 | $225 | $9 |
| Cinacalcet | 12 | $217 | $18 |
| Famotidine | 19 | $209 | $11 |
| Warfarin | 15 | $203 | $14 |
| Triamcinolone Acetonide | 11 | $187 | $17 |
| Glipizide | 22 | $172 | $8 |
| Bupropion | 12 | $170 | $14 |
| Quetiapine | 19 | $149 | $8 |
| Carvedilol | 13 | $137 | $11 |
| Sertraline | 14 | $135 | $10 |
| Cilostazol | 12 | $129 | $11 |
| Amoxicillin-Clavulanate Potass | 14 | $110 | $8 |
| Prednisone | 11 | $48 | $4 |
2022: 50 drugs
| Trulicity | 17 | $21,856 | $1,286 |
| Levemir Flextouch | 14 | $13,216 | $944 |
| Eliquis | 34 | $11,377 | $335 |
| Lantus Solostar | 18 | $6,326 | $351 |
| Jardiance | 11 | $4,583 | $417 |
| Novolog Flexpen | 13 | $4,561 | $351 |
| Pregabalin | 34 | $2,225 | $65 |
| Hydrocodone-Acetaminophen | 85 | $1,752 | $21 |
| Gabapentin | 50 | $1,580 | $32 |
| Levothyroxine | 72 | $1,208 | $17 |
| Warfarin | 74 | $1,056 | $14 |
| Albuterol Sulfate Hfa | 12 | $960 | $80 |
| Tramadol | 49 | $611 | $12 |
| Morphine Sulfate | 21 | $525 | $25 |
| Lisinopril | 73 | $514 | $7 |
| Clopidogrel | 31 | $475 | $15 |
| Losartan | 45 | $460 | $10 |
| Nitrofurantoin Mono-Macro | 17 | $399 | $23 |
| Hydrochlorothiazide | 48 | $395 | $8 |
| Atorvastatin | 38 | $359 | $9 |
| Nystatin | 12 | $354 | $29 |
| Omeprazole | 26 | $345 | $13 |
| Metformin | 53 | $340 | $6 |
| Ondansetron | 16 | $340 | $21 |
| Lorazepam | 22 | $317 | $14 |
| Pantoprazole | 18 | $308 | $17 |
| Metoprolol | 21 | $288 | $14 |
| Potassium Chloride | 11 | $282 | $26 |
| Sulfamethoxazole-Trimethoprim | 28 | $271 | $10 |
| Fluticasone Propionate | 16 | $267 | $17 |
| Simvastatin | 40 | $251 | $6 |
| Clonazepam | 30 | $249 | $8 |
| Sertraline | 18 | $245 | $14 |
| Alprazolam | 19 | $238 | $13 |
| Metoprolol | 39 | $234 | $6 |
| Cephalexin | 15 | $229 | $15 |
| Triamcinolone Acetonide | 13 | $219 | $17 |
| Trazodone | 21 | $205 | $10 |
| Citalopram Hbr | 31 | $194 | $6 |
| Famotidine | 15 | $183 | $12 |
| Pravastatin | 24 | $177 | $7 |
| Furosemide | 22 | $147 | $7 |
| Meloxicam | 18 | $134 | $7 |
| Hydrocortisone | 11 | $131 | $12 |
| Allopurinol | 12 | $122 | $10 |
| Glipizide | 13 | $117 | $9 |
| Amlodipine Besylate | 39 | $104 | $3 |
| Prednisone | 18 | $103 | $6 |
| Lovastatin | 13 | $95 | $7 |
| Spironolactone | 11 | $67 | $6 |
2021: 45 drugs
| Symbicort | 20 | $14,279 | $714 |
| Lantus Solostar | 13 | $12,099 | $931 |
| Xarelto | 15 | $9,907 | $660 |
| Levemir Flextouch | 11 | $6,963 | $633 |
| Albuterol Sulfate Hfa | 27 | $1,988 | $74 |
| Gabapentin | 42 | $1,419 | $34 |
| Hydrocodone-Acetaminophen | 45 | $1,028 | $23 |
| Levothyroxine | 50 | $972 | $19 |
| Atorvastatin | 66 | $864 | $13 |
| Ultra-Fine Mini Pen Needle | 12 | $739 | $62 |
| Fluticasone Propionate | 26 | $720 | $28 |
| Lisinopril | 74 | $677 | $9 |
| Glipizide | 23 | $559 | $24 |
| Pantoprazole | 27 | $507 | $19 |
| Omeprazole | 28 | $505 | $18 |
| Synthroid | 11 | $484 | $44 |
| Morphine Sulfate | 26 | $461 | $18 |
| Warfarin | 43 | $458 | $11 |
| Pravastatin | 29 | $439 | $15 |
| Losartan | 35 | $422 | $12 |
| Amoxicillin-Clavulanate Potass | 18 | $399 | $22 |
| Metoprolol | 25 | $377 | $15 |
| Metoprolol | 43 | $366 | $9 |
| Montelukast | 22 | $356 | $16 |
| Simvastatin | 40 | $341 | $9 |
| Glipizide Er | 13 | $315 | $24 |
| Nystop | 13 | $307 | $24 |
| Meloxicam | 36 | $296 | $8 |
| Metformin | 47 | $292 | $6 |
| Amlodipine Besylate | 49 | $283 | $6 |
| Clonazepam | 18 | $266 | $15 |
| Furosemide | 36 | $238 | $7 |
| Triamterene-Hydrochlorothiazid | 12 | $219 | $18 |
| Alendronate | 17 | $201 | $12 |
| Tamsulosin | 21 | $196 | $9 |
| Tramadol | 20 | $172 | $9 |
| Carvedilol | 11 | $167 | $15 |
| Sertraline | 23 | $153 | $7 |
| Potassium Chloride | 17 | $144 | $8 |
| Hydrochlorothiazide | 37 | $144 | $4 |
| Citalopram Hbr | 17 | $132 | $8 |
| Clopidogrel | 16 | $105 | $7 |
| Atenolol | 12 | $97 | $8 |
| Lovastatin | 16 | $82 | $5 |
| Sulfamethoxazole-Trimethoprim | 11 | $74 | $7 |
2020: 5 drugs
| Hydrocodone-Acetaminophen | 24 | $850 | $35 |
| Lorazepam | 27 | $217 | $8 |
| Warfarin | 24 | $190 | $8 |
| Tramadol | 14 | $93 | $7 |
| Cephalexin | 11 | $88 | $8 |
Money from drug and device companies
$29 in 2025
| 2025 | 2 | 2 | None | $29 |
| 2024 | 1 | 1 | None | $22 |
| 2022 | 2 | 2 | None | $26 |
| 2021 | 1 | 1 | None | $23 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
See all 2 published payments
| Alkermes | Meals · 2025-11-04 | Aristada | $14 |
| Lilly USA | Meals · 2025-09-10 | Mounjaro | $14 |
See earlier years (2024, 2022, 2021)
2024: $22
| Exact Sciences | Cologuard Collection Kit | $22 | 1 payment
|
2022: $26
| AstraZeneca Pharmaceuticals LP | Farxiga | $16 | 1 payment
|
| Organon | Nexplanon | $11 | 1 payment
|
2021: $23
| Bayer HealthCare Pharmaceuticals | Kyleena | $23 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 52.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1851925275
- Licence
- IA A158227, IL 209.020910Illinois 209020910: Active
- Group
- Henderson County Rural Health Center, Inc · Southeast Iowa Regional Medical Center Inc
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LF0000X (363LF0000X)
- Mailing address
- 230 S Main St, Monmouth, IL, 61462
- NPI first listed
- 2020-02-25
- NPI last updated
- 2023-10-25
- NPI record certified
- 2023-10-25
This is when the NPI record was last certified, not a medical board exam.